Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.69 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | HTR5A | P47898 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5237109 | 0.95 | CYP2A6 (0.71) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL4324624 | 0.89 | CYP2A6 (0.75) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL5548229 | 0.84 | CYP2A6 (0.59) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL2092471 | 0.83 | CYP2A6 (0.58) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL8435709 | 0.83 | CYP2A6 (0.61) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL5542371 | 0.83 | CYP2A6 (0.61) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL3180021 | 0.82 | CYP2A6 (1.00) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL31673840 | 0.82 | CYP2A6 (1.00) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3575805 | 0.80 | CYP2A6 (0.96) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL5469050 | 0.79 | CYP2A6 (0.65) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101143867-A | Antidepressant indolealkyl derivatves of heterocyclefused benzodioxan methylamines | WYETH CORP (US) | 2008-03-19 | — | — | CN | disclosed |
| CN-100358898-C | Antidepressant indolealkyl derivatives of heterocycle-fused benzodi * alkylmethylamines | WYETH CORP (US) | 2008-01-02 | — | — | CN | disclosed |
| EP-1537122-B9 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH CORP (US) | 2007-10-31 | — | — | EP | disclosed |
| EP-1537122-B1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH CORP (US) | 2007-08-22 | — | — | EP | disclosed |
| CN-1701075-A | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | WYETH CORP (US) | 2005-11-23 | — | — | CN | disclosed |
| EP-1537122-A1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | Wyeth (US) | 2005-06-08 | — | — | EP | disclosed |
| US-6800637-B2 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | WYETH | 2004-10-05 | — | — | US | disclosed |
| US-20040138222-A1 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | WYETH | 2004-07-15 | — | — | US | disclosed |
| WO-2004024734-A1 | ANTIDEPRESSANT INDOLEALKYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXAN METHYLAMINES | WYETH (US) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138222-A1 | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines | HTR5A, TPH1, DBH | CYP2A6 1160/4885KEAP1 1111/4885NFE2L2 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.